The S&P 500 slipped 0.4% on Tuesday, May 20, snapping a six-day winning streak as investors' confidence on trade and ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The agency will require manufacturers to conduct randomized, controlled trials to secure approval for healthy Americans.

Novavax's shot is now fully approved in the U.S. Since 2022, the vaccine has been used under an emergency use authorization. Health experts consider it a valuable alternative to messenger RNA shots ...

COVID vaccines are only approved for elderly and a few others as RFK continues to reshape how Americans fight disease - ...

Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit future vaccines to older Americans and people at higher risk of serious ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.